Skip to content
Dx

ICD-10-PCS 2027 procedure code

XXE97U7Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7

✓ Valid for 2027

Short description: Measurement of Nasophrn Fluid SARS-CoV-2 PCR, New Tech 7

Code last changed in FY2022 (effective October 1, 2021). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About XXE97U7

XXE97U7 is the ICD-10-PCS code for a measurement procedure on the nose using a via natural or artificial opening approach with infection, nasopharyngeal fluid sars-cov-2 polymerase chain reaction (qualifier: new technology group 7). In ICD-10-PCS, measurement means determining the level of a physiological or physical function at a point in time.

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It was added in FY2022, effective October 1, 2021.

What each character means

1. Section
XNew Technology
2. Body System
XPhysiological Systems
3. Operation
EMeasurement

Determining the level of a physiological or physical function at a point in time

4. Body Part
9Nose
5. Approach
7Via Natural or Artificial Opening

Entry of instrumentation through a natural or artificial external opening to reach the site of the procedure

6. Device / Substance / Technology
UInfection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction
7. Qualifier
7New Technology Group 7

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2022 (effective 10/1/2021): Added
  • No changes since FY2022.

Common questions about XXE97U7

Is XXE97U7 a valid ICD-10-PCS code for 2027?

Yes. XXE97U7 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.